DuPont Pharmaceuticals' Teti Adds CEO To Title With Landgraf Resignation
DuPont President-Pharmaceuticals Nicholas Teti will add Chief Executive Officer to his title with the resignation of Kurt Landgraf, effective May 15.
DuPont President-Pharmaceuticals Nicholas Teti will add Chief Executive Officer to his title with the resignation of Kurt Landgraf, effective May 15.